Janux Therapeutics Inc's market cap is currently $2.15B. The company's EPS TTM is $-1.175; its P/E ratio is ―; Janux Therapeutics Inc is scheduled to report earnings on March 7, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 8.08M	$ 8.61M	$ 3.64M	$ 0.00	$ 0.00
Gross Profit	$ 6.13M	$ 7.77M	$ 3.52M	$ -13.00K	$ -6.00K
Operating Income	$ -72.98M	$ -67.09M	$ -32.93M	$ -4.84M	$ -3.77M
EBITDA	$ -71.02M	$ -66.25M	$ -32.82M	$ -4.83M	$ -3.77M
Net Income	$ -58.29M	$ -54.15M	$ -32.56M	$ -5.25M	$ -4.24M
Balance Sheet
Cash & Short-Term Investments	$ 344.03M	$ 327.02M	$ 374.96M	$ 7.81M	$ 658.00K
Total Assets	$ 380.41M	$ 364.01M	$ 379.82M	$ 16.22M	$ 679.00K
Total Debt	$ 24.54M	$ 25.30M	$ 194.00K	$ 0.00	$ 4.00M
Net Debt	$ 5.34M	$ -26.12M	$ -35.39M	$ -7.81M	$ 3.34M
Total Liabilities	$ 36.06M	$ 43.27M	$ 13.50M	$ 30.86M	$ 8.62M
Stockholders' Equity	$ 344.35M	$ 320.74M	$ 366.33M	$ -14.64M	$ -7.94M
Cash Flow
Free Cash Flow	$ -52.42M	$ -49.37M	$ -18.46M	$ -4.37M	$ -3.83M
Operating Cash Flow	$ -50.58M	$ -42.92M	$ -16.98M	$ -4.37M	$ -3.83M
Investing Cash Flow	$ -41.19M	$ 58.27M	$ -340.96M	$ 0.00	$ 0.00
Financing Cash Flow	$ 59.55M	$ 500.00K	$ 386.52M	$ 11.52M	$ 4.00M

Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Income Statement >

Janux Therapeutics Inc Debt to Assets

Balance Sheet >

Janux Therapeutics Inc Cash Flow

Cash Flow >

Janux Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing